Advanced Search
Contact | Corporate | Help

Daily news email for July 10, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Berthold Launches TriStar² Microplate Reader

Encap Announces $ 2 Million Capital Expenditure Programme

Encap Announces $2M Capital Expenditure Programme

Medicyte Coordinates EU-funded Collaboration on Biomimetic Bioartificial Liver

Anniversary: euroPLX to Hold its 50th Partnering Conference in November

 BioSpace
Small Molecule May Play Big Role in Alzheimer's Disease, University of California, Santa Barbara Study

Nutrient Drink Might Boost Memory in Early Alzheimer's, Cleveland Clinic Study

BioNeutral Appoints as Chief Executive and President

Weight Gain Induced by High-Fat Diet Increases Active-Period Sleep and Sleep Fragmentation, University of Minnesota Study

Facebook Use Leads to Depression University of Wisconsin Study

BioSpace - Breaking News
SFDA Issues New Rules for Drug Excipients

Integrated DNA Technologies Release: Moving Towards Real-Time Imaging in Single, Living Cells

Ingen Technologies, Inc. Continues With Preparations for a National Distribution Program

AspenBio Pharma, Inc. Notified by That It Regained Compliance With All Capital Market Continued Listing Standards

Noble Life Sciences Inc. Announces Collaboration With -- Noble to Manage Neuren Pharmaceuticals Limited Subsidiary's Oncology Program

Biotech News - Business Wire
K2M Launches Expanded Biologics Portfolio Featuring VESUVIUS Osteobiologic & VIKOS® Allograft Systems

Terumo BCT Launches Mononuclear Cell Collection Protocol for Spectra Optia® Apheresis System in the United States

Vitrolife AB (publ): New Vice President at Vitrolife

DSM's VitroStealth® Coating Used in Axis-Shield's Next Generation Afinion® Point-of-Care Cartridge

Samenvatting: NovImmune versterkt zijn raad van bestuur en managemetteam

 Biotech News - PR Newswire
TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimer's Disease Research, His Third Endowed Chair

Everist Genomics Awarded Admission to Johnson and Johnson's Life Science Innovation Center

3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Cells From Parkinson's Patients Show Unique Drug Responses

GSK to Pay $3 Billion to Settle Civil and Criminal Charges with U.S. and States

Pfizer Grants Russia's SatRx Rights to Diabetes Compound

BMS to Acquire Amylin for $5.3 Billion Plus Debt

Sanofi May Slash 2,000 Jobs in France

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Research and Markets: Mitral Regurgitation Global Clinical Trials Review, H1, 2012

First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro's Chronic Pain Treatment

SORIN GROUP INVESTE IN CARDIOSOLUTIONS, START-UP NELLE TECNOLOGIE PER LA VALVOLA MITRALE

Sorin Group Invests in Cardiosolutions, a Development-Stage Company Focused on Mitral Valve Technology

Youngevity® Essential Life Sciences Initiates Clinical Studies at Clemson University's Institute of Nutraceutical Research

 Clinical Trials - PR Newswire
OncoGenex Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung Cancer

Rcadia Announces Results of Initial Study to Demonstrate Feasibility of Method for Assessing Hemodynamic Significance of Coronary Lesions from Coronary CTA

Retina Implant AG Researcher and Trial Patient to Present at International Retina Congress

Forscher und Versuchsteilnehmer der Retina Implant AG treten bei internationalem Retina-Kongress auf

American Obesity Could Affect Population Growth

 CNN Top Stories
Watch cat interrupt reporter's live shot

Egypt's parliament defies military

Should smoking trigger an R rating

I got pregnant to flee Scientology

Four ways the Internet could go down
Contract Pharma
CRI Lifetree Opens New Research Facility

Evotec, Janssen in Strategic Diabetes Pact

Galenea, Eisai in Neurodegenerative Disease Alliance

Ricerca Biosciences Appoints Technical Director

Merck KGaA Licenses Versamune Platform

 FDA Drugs- What's New
FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

FDA Drug Safety Communication: Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

 FDA News - Business Wire
Vitrolife AB (publ): Application for Market Approval of STEEN Solution in the USA Has Been Submitted to the FDA

El revolucionario sistema ARTAS de Restoration Robotics obtiene marca CE para el tratamiento de la pérdida capilar

ABMC Announces Signing of Consent Decree Related to Its OralStat® Product

Great Basin Corporation Launches U.S. and Global Sales Efforts

TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur with the Recent Joint Statement from NAMS, ASRM and The Endocrine Society
FDA Press Releases
FDA approves first over-the-counter home-use rapid HIV test

FDA introduces new safety measures for extended-release and long-acting opioid medications

FDA approves genetic test to help some colon cancer patients, physicians considering Erbitux therapy

FDA approves first DNA test to help manage CMV infection in organ transplant patients

FDA prompts companies to remove certain unapproved oxycodone products from market

 FDA Vaccines, Blood and Biologics - What's New
Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

 FierceBiotech
Struggling Chelsea jettisons staffers, plots survival strategy

Analysis: A buyer's market dominates the H1 biotech deal scene

Ipsen shares slide after FDA orders hold on PhIII hemophilia drug trials

Forest CEO goes mano-a-mano with Carl Icahn

J&J offers up to $300M for each diabetes drug in Evotec/Harvard portfolio
FierceBiotech IT
Supercomputer, sequencing uncover clue to doc's unlikely cancer

Mount Sinai Medical Center, Cloudera embrace Big Data in genomics

ERT scoops up Invivodata for ePRO clinical trials tech

Mytrus aligns leadership for at-home clinical trials biz

Industry Voices: Harness Life Sciences Data, Uncover Insight

 FierceBiotech Research
Mouse model connects specific gene to liver cancer advance

Key molecule spotted as possible lung cancer weapon

Acadia's Parkinson's drug shows promise in treating Alzheimer's psychosis

UPDATED: Groundbreaking cancer study highlights potential immunotherapy for melanoma

Nanomedicine busts deadly clots in promising mouse study

 FiercePharma
Amid Krystexxa woes, Savient plots layoffs and taps new CEO

Ranbaxy lines up plans for U.S. growth

Novartis plant snafu sends desperate Excedrin users to eBay

FDA plan requires opioid makers to fund anti-abuse CME

BMS, Lilly's targeted drug Erbitux gets new FDA nod
FiercePharma Manufacturing
Ireland campus becomes Eli Lilly's launch pad

Albemarle again expands Michigan API plant

AEI suggests booting WHO drugmakers that don't meet the grade

An FDA warning letter often means a tipping point has been reached

Group suggests booting WHO drugmakers who don't meet the grade

FierceVaccines
Immunotherapy bats out Type 1 diabetes in mice

Brigham and Women's aims to stomp out lethal pneumonia

Indonesia to produce bird flu vaccine in 2013

ASU's Biodesign Institute enhances salmonella vaccine safety

Group tackles dengue vaccine pricing

 Health News - BizJournals.com
St. Luke's The Woodlands Hospital opens new floor, continues growth

Home-care case won't impact Buffalo providers

Linde sells stock to fund Lincare acquisition

Mercy nurses reject contract; others OK pact

SLIDESHOW: Inside laser cataract surgery
Health News - CNBC
#4 Top State for Business: North Carolina

North Carolina Places Fourth in CNBC's Top States for Business 2012

Chelsea Therapeutics restructures to save Northera

Study confirms uncircumcised boys' UTI risk

Capitol Hill Showdown on Taxes

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
CureBeta Snags $8M Up Front for Beta-Cell Regeneration Candidates

Breast Cancer Therapy Disappoints

Eisai and Galenea Team Up to Fight Neurodegenerative Diseases

Janssen Pays CureBeta $8M Up Front for Beta-Cell Regeneration Candidates

Eisai's Breast Cancer Therapy Disappoints
Marketwire - Pharma and Biotech
Knovel Announces New Technology Advisory Board

Noble Life Sciences Announces Collaboration With Perseis Therapeutics -- Noble to Manage Neuren Pharmaceuticals Subsidiary's Oncology Program

AspenBio Pharma Notified by NASDAQ That It Regained Compliance With All NASDAQ Capital Market Continued Listing Standards

Dynavax Appoints David Happel Vice President, Global Sales and Marketing

U.S. Cancer Patients Get Faster Access to More Oncology Drugs Than European Patients, According to Tufts Center for the Study of Drug Development

 MassBio News
The Massachusetts Life Sciences Center 2012-13 Accelerator Loan Program

MassBio Commends Governor, Lawmakers for Ensuring Patient Access, Physician Education

Breaking: Supreme Court Upholds Affordable Care Act

MassBio Releases 2012 Complete Guide to the New England Life Sciences Industry at BIO

CB Richard Ellis N.E. Partners, LP Brings MassBio to Alexandria Real Estate Equities, Inc.'s 300 Technology Square

 Medical Pharma - PR Newswire
UBM Medica US Unveils New iPad Application for Oncology Professionals

The American College Of Wound Healing and Tissue Repair Announces Open Registration for Second Annual Meeting

INTEGRIS Implements Amalga To Improve Care Coordination, Patient Engagement And Care Quality

Okuvision GmbH's Breakthrough Technology to Be Featured at Retina International World Congress

The Future of the Oral Hygiene Market in China, to 2016
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

 New York Times- Biotechnology
Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy
New York Times- Pharmaceuticals
F.D.A. Rejects Mandatory Training in Painkillers for Doctors

F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug

Drug Firm Guilty In Criminal Case

OxyContin’s Effect on Children in Testing by Purdue Pharma

Three Mutual Funds That Turned Back the Tide of Losses

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Research and Markets: Multaq (Atrial Fibrillation) - Analysis and Forecasts to 2022

Metabolon Technology Now Available in Germany with Validation of Helmholtz Zentrum Muenchen Laboratory

Resumen: AllumeTM de Quintiles ayuda a las empresas biofarmacéuticas al lanzamiento de nuevos productos al mercado

Samenvatting: Allume van Quintiles helpt biofarma bedrijven bij markttoetreding

Prescription-Only Medical Foods Found Beneficial in Clinical Practice

 Pharma News - PharmiWeb
23andMe Acquires CureTogether, Inc.

Jacobs Awarded Contract from National Institutes of Health

Winola Lake Announces Investment; Exclusive Partnership with Innovative Communication Technology Company

HealthHelp CMO Dr. Mark Hiatt Presents Webinar: How Can Specialty Benefits Management Supercharge Accountable Care Organizations

Oxford BioMedica Announces Initiation of Phase II Collaborative Study for TroVax® in Colorectal Cancer

 Pharma News - PR Newswire
Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences

Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call

NIPTE Will Participate in NIH's Therapeutics for Rare and Neglected Diseases (TRND) Program

Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion

Arbor Pharmaceuticals partners with the Association of Black Cardiologists to further the campaign of "Saving Hearts of a Diverse America"
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
Dr. Jue Brings Store-A-Tooth Dental Stem Cell Therapy Service to...

Booth Space Reservations Open for Pittcon 2013 Discounted Rate...

Get the BUZZ on Bees

Late Pregnancies and Technological Advancement Drives the Global...

QuantiScientifics, LLC (Irvine, CA) will Introduce the Oligo-Link-it...
PRWeb - Pharmaceuticals
Package All Launches a New Website Designed for Busy People, Like You

Cyber Security firm, Passfaces Corporation, adds Federal Marketing...

GS1 US Applauds U.S. FDA for Releasing Draft Regulation Requiring...

New Regional Director Joins BioPlus Team

Top Five Signs and Symptoms of Topical Steroid Induced Eczema

 Scientific American
Dead Zone Pollutant Grows Despite Decades of Work

Single Genetic Variant Is Linked to Multiple Sclerosis Risk

Better Preparation Could Improve the Quality of Death--and Life--for Terminal Patients

Notorious Arsenic-Tolerant Bacterium Needs Phosphorus After All

Why We Sunburn

 Sports - ESPN Basketball
Calipari weighing D.R. future after Olympic exit

Lawyer rips Syracuse sex-abuse probe report

Cal's Montgomery signs deal through 2015-16

Ex-Stanford captain Sauer dies in pickup game

Medcalf: Rise of the elite Canadian prospect
Sports News - ESPN
Report: Dawgs loss of RB Crowell 'best thing'

ND says it's had Orange Bowl talks with ACC

August 17 hearing set for Spanier's email suit

Ex-Rutgers DL LeGrand nets endorsement deal

Penn St. says donations 2nd highest in history

 Xconomy Life Sciences
Halo Report: Angel Investing Holds Steady in First Quarter

Gates Foundation's Jeff Raikes To Start Off Seattle Biotech Event

Sophiris Moves to Unlock Blockbuster Potential in New Prostate Drug

Lux Bio Resurfaces With Defined Path for Pill for Rare Eye Disease

The Best Boring Companies in Biotech

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012